Intra Arterial Heparin Flushing Increases Manual Muscle Test – Medical Research Councils (MMT-MRC) Score in Chronic Ischemic Stroke Patient

Terawan Agus Putranto , Irawan Yusuf, Bachtiar Murtala, Andi Wijaya

Terawan Agus Putranto
Hasanuddin University. Jl. Perintis Kemerdekaan. Km.10. Makassar. Sulawesi Selatan.. Email: terawan@rspadgs.net

Irawan Yusuf
Faculty of Medicine, Hasanuddin University, Makassar-Indonesia

Bachtiar Murtala
Faculty of Medicine, Hasanuddin University, Makassar-Indonesia

Andi Wijaya
Faculty of Medicine, Hasanuddin University, Makassar-Indonesia
Online First: May 11, 2016 | Cite this Article
Putranto, T., Yusuf, I., Murtala, B., Wijaya, A. 2016. Intra Arterial Heparin Flushing Increases Manual Muscle Test – Medical Research Councils (MMT-MRC) Score in Chronic Ischemic Stroke Patient. Bali Medical Journal 5(2): 216-220. DOI:10.15562/bmj.v5i2.200

Background: Muscle strength impairment in stroke patient affect the patient daily life, especially when it occurs on the extremities muscles. Manual Muscle Testing (MMT) is an examination method to measure muscle strength using standardized scoring. Objectives: To find possible improvement of Manual Muscle Test (MMT) Score after administration of Intra Arterial Heparin Flushing in chronic ischemic stroke patient. Methods: This is an experimental study using pretest-posttest group design, with randomized controlled clinical trial, conducted among patients in Cerebrovascular Center Unit in Army Central Hospital Gatot Soebroto starting from February 2014. With 75 patients included in this study. The examination of muscle strength was done by trained physicians. The MMT score were taken before and after the IAHF procedure is conducted. Results: This study found higher score of MMT-MRC scoring system on chronic stroke patient with IAHF procedure (mean MMT-MRC Score = 6,05 point. With p<0,05). Indicating that IAHF procedure is associated with better muscle strength improvement shown with higher MMT-MRC score on stroke patient, which will have better prognostic outcome in their recovery. Conclusions: Intra Arterial Heparin Flushing have significant effect on chronic stroke patient with decreased muscle strength, which shows a significant increase of MMT-MRC score.


Sacco R., Kasner S., Broderick J., et al. 2013. An Update Definition of Stroke for the 21st Century. American Heart Association/American Stroke Association, Stroke. 2013;44:2064-2089.

Rathore S., Hinn A., Cooper L., Tyroler H., Rosamond W., 2002. Characterization of Incident Stroke Signs and Symptoms. Stroke. 2002;33:2718-2721.

Lawrence E., Coshall C., Dundas R., et al. 2001. Estimates of the Prevalance of Acute Strokes Impairments and Disability in a Multiethnic Population. Stroke. 2001;32:1279-1284.

Dobkin B., 1997. Journal of Stroke and Cerebrovascular Diseases, Vol.6 No. 4. 1997:pp 221-226

Tae-Kim J., Park-Seok M., Kang-Ho C., 2016. Different Antiplatelet Strategies in Patients with new Ischemic Stroke While Taking Aspirin. Stroke. 2016;47:128-134.

Paternostro-Sluga T., Stieger-Grim M., Posch M., 2008. Reliability and Validity of The Medical Research Council (MRC) Scale and A Modified Scale for Testing Muscle Strength in Patients with Radial Palsy. J Rehabil Med 2008;40:665-671.

Coull, B.M., Williams, L.S, Goldstein, L.B., et al. 2002. Anticoagulants and Antiplatelet

Agents in Acute Ischemic Stroke : Report of the Joint Stroke Guideline Development

Committee of the American Academy of Neurology and the American Stroke

Association (a Division of the American Heart Association). Stroke. 33: 1934-1942

Coutinho, J., de Bruijn, S. F. T. M., deVeber, G., Stam, J. 2011.Anticoagulation for

Cerebral Venous Sinus Trombosis.Cochrane DB Syst Rev. 8: 1- 21.

Dalkara,T., Arsava,E.M. 2012. Can Restoring Incomplete Microcirculatory

Reperfusion Improve Stroke Outcome After Thrombolysis. Journal of Cerebral Blood

Flow Metabolism.32: 2031-2099.

Deb, P., Sharma, S., Hassan, K.M. 2010. Pathophysiologic Mechanism of Acute

Ischemic Stroke: An Overview with Emphasis of Therapeutic Significance Beyond

Thrombolysis. Pathophysiology. 17: 197 – 218.

Durran, A. C., dan Watts, C. 2012.Current Trends in Heparin Use During Arterial

Vascular Interventional Radiology.CardiovascInterventRadiol.35: 1308-1314.

Dvorak, M., Vlasin, M., Dvorakova, M., et al. 2010. Heparin and its Derivatives in

the Treatment of Arterial Trombosis: A Review. Vet Med. 55: 523–546.

Font, M. A., Arboix, A., Krupinski, J. 2010. Angiogenesis, Neurogenesis and

Neuroplasticity in Ischemic Stroke. CurrCardiol Rev. 6: 238-244.

Gutiérrez, L. M., Díez, Tejedor, E., Alonso de Leciñana, M., Fuentes, B., Carceller,

F.,Roda, J. M. 2006.Thrombolysis and Neuroprotection in Cerebral

Ischemia.Cerebrovasc Dis. 21:118-26.

Hurtado, O., Pradili, J. M., Alonso-Escolano, D., Lorenzo, P., Sobrino, T., Castillo,

J., Lizasoain, I., Moro, M. A. 2006.Neurorepair versus Neuroprotection.Stroke. 21 (2):


Kaste, M., Mikulik, R., Kostulas, N., et al. 2008.Should the time window for

intravenous thrombolysis be extended? 7th Karolinska Stroke Update meeting on

November 18, 2008. (Online)

(http://www.strokeupdate.org/Cons_thrombolysis_2008.aspx, diakses 25 Spetember


Kilic, C., Bassetti, C. L., Kilic, E., Wang, Z., Hermann, D. M. 2005.Post-Ischemic

Delivery of the 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor

Rosuvastatin Protects Agains Focal Cerebral Ischemia in Mice via Inhibition of

Extracellular-Regulated Kinase -1/-2.Neuroscience. 134: 901-906.

Lewis, J. H., Kerber, C. W., Wilson, J. H. 1964. Effects of Fibrinolytic Agents and

Heparin on Intravascular Clot Lysis.Am J Physiol.207: 1044-1048.

Nawashiro, H., Wada, K., Nakai, K., Sato, S. 2012. Focal Increase in Cerebral Blood

Flow After Treatment with Near-Infrared Light to the Forehead in a Patient in a

Persistent Vegetative State.Photomedicine and Laser Surgery. 30(4): 231-233.

Perrey, S. 2013. Promoting Motor Function by Excercising the Brain. Brain

Sciences. 3: 101-122.

Sacco, R. L., Kasner, S. E., Broderick, J. P. et al. 2013. An Updated An Updated

Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals

From the American Heart Association/American Stroke Association. Stroke 44 : 2064

Slevin, M., Kumar, P., Gaffney, J., Kumar, J., Krupinski, J. 2006. Can Angiogenesis

Be Exploited to Improve Stroke Outcome? Mechanism and Therapeutic Potential.Clin

Sci. 111: 171-183.

The Internet Stroke Center. 2014. Acute Infarction .(Online) http://www.strokecenter.org/professionals/stroke-diagnosis/ neuropathology-image-library/acute-infarction/, diakses 25 September 2014).

Schellinger, P.D., Fiebach, B.J., Mohr, A., Ringleb, P.A., Jansen, O., Hacke, W. 2001. Thrombolytic Therapy for Ischemic Stroke. Crit Care Med. 29(9): 1812-8.

Liang, J. F., Li Y., Yang V. C., 2000. The Potential Mechanism for The Effect of Heparin on Tissue Plasminogen Activator-mediated Plasminogen Activation. Thromb Res.97(5): 349-58.

Colucci M., Pentimone A., Binetti, B.M.,Cramarossa M., Piro D., Semeraro N. 2002. Effect of Heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin. 88(2):282-7.

Pollard, H. Lakay, B., Tucker, F., Watson, B., Bablis, P. 2005. Interexaminer

Realibility of The Deltoid and Psoas Muscle Test. J Manipulative Physiol Ther;

(1): 52-6.

Taher, E., Hamdy. G., Abu Farha, M., Awad, M. 2010. Predictors of Stroke Outcome

in Egyptian Patients Following Acute Stroke. The Egyptian J Comm Med : 28 : 1 – 13.

Yen-Mou, L., Yi-Jing, L. 2012. Musc Dystrophy. 17: 322-330.

Gregson, J.M., Leathley, J.M., Moore, A. P., Smith, T. L., Sharma, A. K., Watkins, C.

L. 2000. Reliability of Measurements of Muscle Tone and Muscle Power in Stroke

Patients. Age and Ageing. 29: 223-228.

Schwerin,S.,2013. The Anatomy of Movement (Online)

(http://brainconnection.brainhq.com/2013/03/05/the-anatomy-of-movement/, diakses 12

September 2014)

Silva-Coto, Mde A., Prado-Medeiros, CL., Oliveira, AB., Alcantara, CC., Guimaraes,

AT., Salvini Tde F., et al. 2014. Muscle Atrophy, Voluntary Activation Disturbances, and

Low Serum Concentrations of IGF-1 and IGFBP-3 are Associated with Weakness in

People with Chronic Stroke. Phys Ter.; 94(7): 957-67.

Guggenmos, D.J., Azin, M., Barbay, S., Mahnken, J.D., Dunham, C., Mohseni, P., et

al. 2013. Restoration of function after brain damage using a neural prosthesis.

Neuroscience. 110(52): 21177-21182.

Muhammad, S.bin I., Gofir, A., Ismail, S., 2014. Reability of Manual Muscle Test

Examination of Stroke Patient in Sardjito Hospital. Department of Neurology. Gadjah

Mada University, Jogjakarta.

Langhorne, Peter., Coupar, Fiona., Pollock, Alex. 2009. Motor Recovery After

Stroke: A Systematic Review. Lancet Neurol. 8: 741-54.

No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0